Six months in, TrumpRx is giving American patients something their insurance too often will not: a price they can actually pay, today, with no appeal to file and no prior authorization.
TrumpRx is a government-facilitated cash-pay platform. Patients buy their prescriptions directly at lower prices, outside the denial-and-appeal cycle that can leave a medication sitting behind the pharmacy counter for weeks. Since its February launch, patients, pharmacists, and policy experts across the country have been putting that change into their own words.
Here is what they are saying.
Patients: Tired of Battling Their Insurance
TrumpRx makes a difference: Joani Harlan learned that she had PCOS and insulin resistance in college and later found real relief on Wegovy, which stabilized her blood sugar and normalized her A1C. Her insurer denied coverage, treating a medically necessary prescription as a blanket GLP-1 exclusion. TrumpRx let her buy the medication at a price she could afford.
“TrumpRx is making a real difference for patients who are tired of battling their insurance over access to medications.” — Joani Harlan
TrumpRx delivers lower prescription costs: Christine Verdier had been paying $499 a month out of pocket for Wegovy after her insurer discontinued coverage of weight-management prescriptions. She found the same medication listed on TrumpRx at a lower price and has used the program ever since.
“TrumpRx is exactly the kind of patient-first solution we need more of.” — Christine Verdier
TrumpRx gives patients a lifeline: Walt and Rita Tuchalski faced an insurance denial the same day Rita went to pick up her prescription. TrumpRx had just launched, and the price they found there was more than 50% below the pharmacy’s list price. Rita bought her prescription outright while the appeal was still pending.
“It fills the gap when insurance falls short.” — Walt and Rita Tuchalski
When insurance fell short, TrumpRx gave NJ patient access: Garrett Glass survived a heart attack in 2023 and has spent years fighting insurance delays and denials, most recently over a GLP-1 his doctor prescribed to manage his cardiovascular risk. He found the same medication on TrumpRx at an 85% discount off list price, with no prior authorization maze to navigate.
“That kind of access isn’t just convenient, it’s essential.” — Garrett Glass
Why the Same Drug Costs $600 Here and $35 in Italy
Not every TrumpRx supporter arrived through a denial letter. Some arrived through the price gap itself when traveling overseas.
Averel Meden, a senior fellow at the Foundation for Government Accountability, wrote about the decades she spent managing asthma with a $600-a-month medication. An emergency in Italy forced her to find it locally and she filled the same prescription for just $35. That gap between what Americans pay and what the rest of the world pays is exactly why she sees the value in discounted cash-pay options, like TrumpRx.
“Trump is fighting to fix this broken system.” — Averel Meden
What Pharmacists Say about TrumpRx
The people filling these prescriptions see the change up close.
The Flathead Beacon spoke with pharmacists in northwest Montana who described TrumpRx as a practical solution. Kimberly Murray, who owns two Flathead Valley pharmacies, said the site is easy for patients to use and has been a real breakthrough for people paying cash for drugs like Wegovy that insurance often doesn’t cover.
“Now we have a solution for those people that thought that it was unattainable.” — Kimberly Murray
At the same time, Murray and other pharmacists in the area noted real limits: patients enrolled in Medicare or Medicaid are often ineligible for TrumpRx coupons. TrumpRx is one tool in the fight to lower prescription costs, not a complete fix. There is more to be done before every patient feels this kind of relief.
What Congress Can Do Next
Congress has a straightforward fix available and conversations are happening across Capitol Hill.
Right now, when patients use TrumpRx or pay cash for their prescriptions, that spending doesn’t count toward their deductible or out-of-pocket maximum, even when it’s the same medication their plan would have covered anyway, just at a higher price. It’s a gap in the rules, and one Congress can close.
Jared Whitley made that case in the Washington Examiner, pointing to polling that found 70% of Americans want insurers to cover TrumpRx drugs without marking up the price.
“Savings realized by lower-cost purchasing models such as TrumpRx should count toward patients’ deductibles.” — Jared Whitley
Representative Greg Murphy’s Every Dollar Counts Act (H.R. 8270) would do exactly that, allowing cash-pay purchases, including those made through platforms like TrumpRx, to count toward a patient’s deductible and out-of-pocket maximum. That solution polled at 83% support nationally. It’s a simple, common-sense fix that stops insurers from penalizing patients for finding lower-priced options.
Patients shouldn’t have to choose between a lower price and credit toward their deductible. Congress can close that gap so more patients can access the medicines their doctor prescribed, at a price they can afford.
